Liver transplant (LT) is the only curative treatment option for patients with end-stage liver disease, with more than 6000 performed annually in the United States.^[@bib1]^ Liver transplantation is a major surgery for patients who are potentially highly compromised by both liver disease and comorbid conditions and is associated with a high risk of postoperative complications and readmission.^[@bib2],[@bib3]^ Post-LT patients are frequently monitored in intensive care units, although the necessity of this as a routine practice is controversial, and a fast-track approach to selected patients is becoming more widely practiced.^[@bib4]-[@bib7]^ The ability to stratify post-LT patients' risk of postoperative complications before operating room exit would be of benefit in both the identification of high-risk patients and the fast-tracking of low-risk patients.

Currently, patient selection for liver transplantation is based on the model for end-stage liver disease (MELD) score. Although the MELD score is a good predictor of pretransplant mortality, it has not been shown to be a strong predictor of posttransplant outcomes.^[@bib8]^ Other scoring systems to predict posttransplant outcomes have been developed, but none have been widely used in direct clinical practice.^[@bib9]-[@bib11]^

Although scoring systems have been developed for outcomes based on preoperative variables, to our knowledge, no scoring system for liver transplants has been developed using strictly intraoperative variables. The surgical Apgar score (SAS) is a 10-point scale first described in 2007 by Gawande et al,^[@bib12]^ as a simple means of grading patients after general or vascular operations using 3 intraoperative variables: lowest heart rate (HR), lowest mean arterial pressure (MAP), and estimated blood loss (EBL) (Table [1](#T1){ref-type="table"}). It has since been validated as predictive of early postoperative outcomes in a number of surgeries,^[@bib13]-[@bib18]^ including abdominal^[@bib6],[@bib19]^ and vascular operations,^[@bib12],[@bib16]^ but has not been studied specifically in the liver transplant population. One reason may be that the EBL category in liver transplantation frequently meets or exceeds the maximal score in the SAS (\>1000 mL).

###### 

The original SAS^*a*^
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Blood loss in LT may be difficult to estimate, and providers often use transfusion requirement as a surrogate. Miki et al^[@bib20]^ have described a procedure-specific adjustment to the SAS, which resulted in improved predictive ability in gastrectomy patients. We therefore hypothesized that a modification of the SAS, substituting appropriate categories of volume of intraoperative blood transfused in place of EBL, could be developed for the liver transplant population and would be a predictor of short-term outcomes. Such a score may be of clinical utility in guiding decisions regarding posttransplant fast-tracking or intensive care assignment.

MATERIALS AND METHODS
=====================

Data Collection
---------------

After receiving approval from the Mayo Clinic Institutional Review Board as minimal risk (ID 14-003485), data was collected from 628 consecutive liver transplantations performed in 613 adult patients older than 17 years between July 2007 and November 2013. Only patients who had provided prior authorization for the use of their medical records for research were included in the study. Retransplantations within 30 days and combined heart/liver transplants were excluded as were transplants in which intraoperative mortality occurred. The primary surgical approach was the piggyback technique with caval interposition. Venovenous bypass was used only when caval interposition was not feasible. Anesthesia was provided by a dedicated liver transplant anesthesia team using a volatile-based technique. Advanced invasive monitoring including the placement of a pulmonary artery catheter was routine. Laboratory support was provided by an in-OR "stat" laboratory and included the use of viscoelastic testing. At the conclusion of surgery, patients were transferred to the intensive care unit for further management.

Preoperative, intraoperative, and postoperative variables were collected, including demographic, comorbidity, hemodynamic, and transfusion data. Mortality and major morbidity within 30 days of transplant were identified. Major morbidities were new diagnoses of myocardial infarction, cardiac arrest, stroke, pulmonary embolism, and respiratory failure requiring reintubation, renal failure requiring hemodialysis, sepsis, and seizures.

Patient data were obtained and confirmed from the electronic medical record using an institution-based query-building tool (Data Discovery and Query Builder^[@bib21]^) and from the institution's prospectively maintained liver transplant database. Intraoperative hemodynamic and fluid management data were abstracted from the anesthesia record (Anesthesia Information Management System \[PICIS ChartPlus, Wakefield, MA\]) in 10-minute nonoverlapping intervals as described by Hyder et al.^[@bib22]^ Additional demographic, comorbidity, and outcome data were collected by electronic text and International Statistical Classification of Diseases and Related Health Problems-9 code search of patient notes using Data Discovery and Query Builder followed by manual review. In the case of conflicting information, the discharge summary (for non-intraoperative variables) and anesthesia record (for intraoperative variables) took precedence. A confirmed physician diagnosis of each outcome variable (eg, myocardial infarction) was required; however, severity was not differentiated. MELD, Sequential Organ Failure Assessment (SOFA), and Acute Physiology and Chronic Health Evaluation III (APACHE 3) scores were calculated based on preoperative, intraoperative, and intensive care data.^[@bib23]-[@bib25]^ All data were collected using Microsoft Excel and JMP software (Microsoft Corporation, 2010, and SAS Institute Inc., 2012, respectively).

Statistical Analysis
--------------------

### Development of SAS-LT

A SAS for liver transplant (SAS-LT) was developed using lowest intraoperative HR, lowest MAP, and transfusion volume. Lowest HR and MAP were categorized based on the cutpoints specified by the SAS.^[@bib12]^ Transfusion volume was analyzed as a continuous variable, and also categorically with cutpoints established after reviewing receiver operating characteristic (ROC) curves. Blood transfusion volume was divided into quartiles, and a score from 0 to 3 was assigned according to descending quartiles with adjustment of volumes to nearest 1000-mL value.

### Outcome Prediction

The classificatory ability of the SAS-LT, SOFA, APACHE 3, and MELD scores for death or severe complications were compared by ROC analysis. The associations of scoring systems with death or severe complications were analyzed separately for dichotomous outcomes using multivariable logistic regression. Additional ROC analysis was also performed using the SAS-LT components as continuous variables both combined and individually. Area under the curve (AUC) estimates for individual SAS-LT components were obtained by logistic regression models. Two-tailed *P* values of 0.05 or less were considered statistically significant, and findings were summarized using point estimates and 95% confidence intervals.

RESULTS
=======

Six hundred thirteen patients underwent 628 liver transplants during the study period. Two hundred thirty-four (37.3%) were female patients. Combined liver-kidney transplants comprised 58 (9.2%). Median MELD was 18.9 (interquartile range \[IQR\], 11.5-28.7). Patient demographics and donor data are shown in Tables [2](#T2){ref-type="table"} and [3](#T3){ref-type="table"}.

###### 

Patient characteristics
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###### 

Patient comorbidities, n (%)
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Death or any severe complication occurred after 105 (16.7%) procedures, mortality within 30 days occurred in 5 (0.8%) cases. The frequencies of complications are shown in Table [4](#T4){ref-type="table"}.

###### 

Complications, n (%)
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The final SAS-LT scoring system is shown in Table [5](#T5){ref-type="table"}. The mean SAS-LT score was 6.3 (SD, 1.5). The SAS-LT AUC for death or severe complications was 0.57 (IQR, 0.51-0.63) (*P* = 0.020) (Table [6](#T6){ref-type="table"}). Additional ROC analysis using the SAS-LT components showed that RBC transfusion was the single strongest predictive component (AUC, 0.61; *P* \<0.001) compared with HR and blood pressure (AUC, 0.51, 0.58; *P* = 0.826, 0.012, respectively) (Table [6](#T6){ref-type="table"}). The APACHE 3, MELD, and SOFA score AUCs were 0.57, 0.56, and 0.62 (*P* = 0.024, 0.059, \<0.001, respectively).

###### 

Modified SAS for liver transplant, SAS-LT
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###### 

Association of MELD, SOFA, APACHE 3, and surgical Apgar components with death or severe complications^*a*^
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Finally, we evaluated the relationship between SAS-LT and ICU discharge within 24 hours. Seventy-nine (12.6%) patients were discharged from the ICU in ≤24 hours. SAS-LT for these patients was significantly higher than those with a longer stay (7.0 vs 6.2, *P* \< 0.01). SAS-LT alone had an AUC of 0.64 (0.58-0.70). After multivariable analysis including SAS-LT, age, MELD, preoperative ICU stay, cold ischemia time, and use of expanded donor criteria, the AUC was 0.67 (0.61-0.73).

DISCUSSION
==========

In this study, we found that the SAS can be adapted for liver transplantation and that the adapted score (SAS-LT) is associated with both major perioperative morbidity and mortality or early ICU discharge according to the score. When compared with other scoring systems, the SAS-LT had similar discriminant abilities to MELD and APACHE 3 for mortality and major morbidity, while the SOFA was the most discriminant.

The SAS-LT has some advantages over other scoring systems. The data points are easily obtained, easily calculated, and immediately available at the end of surgery for postoperative decision-making. They do not require sophisticated monitoring or elaborate calculations.^[@bib12]^ The SAS-LT is tailored to a specific patient population (those with end-stage liver disease meeting transplant criteria) and specific surgery (orthotopic liver transplant). The volume of transfused red cells is a more objective measurement than EBL and may be an appropriate variable for applying the SAS to other surgeries for which blood loss may be extensive or difficult to quantify.

Because the SAS-LT can be obtained in the immediate postoperative phase, the score is available to clinicians earlier than the APACHE 3 or SOFA scores, which use the worst values obtained in the first 24 hours of ICU care.^[@bib24],[@bib25]^ Many hospitals use fast-tracking systems, in which patients' care processes are streamlined based on acuity.^[@bib7]^ A higher SAS-LT may indicate better candidacy for a fast-tracking protocol, whether in the ICU or a step-down unit, although it should not supersede clinician judgment. As the SAS-LT had an AUC of 0.64 in this case, it may be a better predictor of fast-track eligibility than it is of morbidity or mortality. However, this would need to be confirmed with a prospective trial.

When we evaluated the components of SAS-LT individually, we found that blood transfusion was the strongest individual component followed by minimum BP; minimum HR showed no significant association with outcomes. In liver transplantation, many studies have demonstrated an association of increased blood transfusion requirements with poor outcomes. Cywinski et al^[@bib26]^ found that mortality related to red cell transfusion peaked within 2 weeks of liver transplant. Other studies have also shown a strong association with blood transfusion requirement and early morbidity or mortality.^[@bib27],[@bib28]^ In fact, volume of RBCs transfused alone performed better than the SAS-LT according to AUC analysis (0.61 vs 0.57). Amount of RBCs transfused could be further studied as an independent predictor of postoperative outcomes.

Previous studies have identified low intraoperative BP as associated with adverse outcome.^[@bib29]-[@bib31]^ The lack of association between lowest HR and outcome is in contrast to the findings of Gawande et al in formulating the SAS. The reason for this is unclear---it may be related to the deranged cardiovascular physiology associated with liver dysfunction or to the frequent use of beta blockade in this patient population for management of portal hypertension. In addition, although we did not explicitly collect data on surgical technique. During the study period, the primary surgical technique was the piggyback technique with caval interposition; venovenous bypass was only used when this could not be performed (\<5% of cases). The alterations in vital signs could have been related to caval manipulation or other surgical maneuvers. That the HR component of the SAS-LT was ineffective does raise the possibility that substitution of a different intraoperative variable or variables may improve SAS-LT; several cardiovascular parameters including mean pulmonary artery pressure, cardiac output, central venous pressure, and blood pressure lability have previously been linked to outcome.^[@bib19],[@bib20],[@bib30]^

The adaptation of SAS required us to revise the blood transfusion categories from the original. Although the categories are appropriate for our transfusion practice over the period studied, it should be noted that there is a wide range of transfusion practices reported amongst liver transplant programs with similar outcomes.^[@bib26]^ It is therefore possible that SAS-LT it is not generalizable to other institutions. However, the methodology we used to identify the blood transfusion categories could be used to develop a customized score if this were the case. Also, blood transfusion requirements during liver transplantation have been declining over time, so it is possible that the transfusion categories may require adjustment should this trend continue.^[@bib32],[@bib33]^

The main limitations of this study are its retrospective nature and reliance on single institution data. Before using SAS-LT in clinical decision-making, prospective validation should be undertaken. Given the potential for institution-specific practices to influence perioperative variables, especially in relation to transfusion, multicenter validation should also be pursued.

All scoring systems in this study had AUCs less than 0.63, which may not be high enough to be clinically meaningful. Further study into other intraoperative variables as predictors of liver transplant outcomes is warranted. Based on our findings, volume of RBCs transfused should be studied as an independent predictor of outcomes. Central venous pressure, mean pulmonary artery pressure, cardiac output, and blood pressure lability have been shown to correlate with postoperative outcomes and may also be appropriate parameters for an intraoperative scoring system.^[@bib29],[@bib31],[@bib34]^ Change in hemoglobin and vasopressor requirements could also be investigated as possible predictors. Furthermore, emerging techniques, such as transesophageal echocardiography and thromboelastography, are becoming more commonly used and may provide further insight into intraoperative factors affecting outcomes.^[@bib35]^ Because the electronic medical record system is more widely adopted, there may be opportunity to develop more sophisticated and accurate calculators that incorporate both preoperative and intraoperative data that may result in improved prediction of postoperative morbidity and mortality.

CONCLUSIONS
===========

The SAS-LT is an easily calculated score specific to liver transplant patients. It has an association with perioperative outcomes and may provide useful information to assist in allocating postliver transplant resources.
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